| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |